ARTICLE | Clinical News
Compugen preclinical data
July 19, 2010 7:00 AM UTC
In a mouse model of RRMS, CGEN-15001 resulted in complete eradication of spontaneous relapses when administered after disease onset. When administered before disease onset, CGEN-15001 demonstrated a p...